Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
223Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice | European Journal of Nuclear Medicine and Molecular Imaging
Overall survival from the date of progression.
Overall survival from date of LMD relapse. Median survival 39 days (95%... | Download Scientific Diagram
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed | Nature Reviews Clinical Oncology
27 Survival analysis | The Epidemiologist R Handbook
Overall survival in days from initial diagnosis | Download Scientific Diagram
Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study - Jansen - 2018 - Psycho-Oncology - Wiley Online Library
Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study - The Lancet Public Health
Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma - ScienceDirect
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text
Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma | Haematologica
The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma | Radiation Oncology | Full Text
Chapter 20 Survival Analysis | Econometrics for Business Analytics
Full article: Impact of delays in definitive treatment on overall survival: a National Cancer Database study of patients with Hodgkin lymphoma
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC | NEJM
Introduction to Survival Data
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib | Leukemia
A Cumulative of overall survival over 28 days between severe patients... | Download Scientific Diagram
Oncotarget | Clofarabine/busulfan-based reduced intensity conditioning regimens... | Oncotarget
Emergency resection is an independent risk factor for decreased long-term overall survival in colorectal cancer: a matched-pair analysis | World Journal of Surgical Oncology | Full Text
Survival Analysis in R
